These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26139833)

  • 1. Cancer, Warts, or Asymptomatic Infections: Clinical Presentation Matches Codon Usage Preferences in Human Papillomaviruses.
    Félez-Sánchez M; Trösemeier JH; Bedhomme S; González-Bravo MI; Kamp C; Bravo IG
    Genome Biol Evol; 2015 Jul; 7(8):2117-35. PubMed ID: 26139833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subfunctionalisation of paralogous genes and evolution of differential codon usage preferences: The showcase of polypyrimidine tract binding proteins.
    Bourret J; Borvető F; Bravo IG
    J Evol Biol; 2023 Oct; 36(10):1375-1392. PubMed ID: 37667674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COUSIN (COdon Usage Similarity INdex): A Normalized Measure of Codon Usage Preferences.
    Bourret J; Alizon S; Bravo IG
    Genome Biol Evol; 2019 Dec; 11(12):3523-3528. PubMed ID: 31800035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel polymerase chain reaction method for detecting cutaneous human papillomavirus DNA.
    Sasagawa T; Mitsuishi T
    J Med Virol; 2012 Jan; 84(1):138-44. PubMed ID: 22052582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology and pathological associations of the human papillomaviruses: a review.
    Cheah PL; Looi LM
    Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phylogenetic analysis of the human papillomavirus type 2 (HPV-2), HPV-27, and HPV-57 group, which is associated with common warts.
    Chan SY; Chew SH; Egawa K; Grussendorf-Conen EI; Honda Y; Rübben A; Tan KC; Bernard HU
    Virology; 1997 Dec; 239(2):296-302. PubMed ID: 9434721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three novel papillomaviruses (HPV109, HPV112 and HPV114) and their presence in cutaneous and mucosal samples.
    Ekström J; Forslund O; Dillner J
    Virology; 2010 Feb; 397(2):331-6. PubMed ID: 19969321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of human papillomaviruses in warts and cancer.
    Proby CM; Harwood CA
    Hosp Med; 1998 Jan; 59(1):33-6. PubMed ID: 9798562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic diversity of human papillomaviruses (HPV) and clinical implications: an overview in adulthood and childhood.
    Mammas IN; Spandidos DA; Sourvinos G
    Infect Genet Evol; 2014 Jan; 21():220-6. PubMed ID: 24291228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of infection by human papillomavirus.
    Brendle SA; Bywaters SM; Christensen ND
    Curr Probl Dermatol; 2014; 45():47-57. PubMed ID: 24643177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biology of human papillomaviruses: from warts to cancer.
    Laimins LA
    Infect Agents Dis; 1993 Apr; 2(2):74-86. PubMed ID: 8162357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection.
    Cheung YK; Cheng SC; Sin FW; Xie Y
    Vaccine; 2004 Dec; 23(5):629-38. PubMed ID: 15542183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
    Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
    J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes.
    Leder C; Kleinschmidt JA; Wiethe C; Müller M
    J Virol; 2001 Oct; 75(19):9201-9. PubMed ID: 11533183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal papillomaviruses.
    Rector A; Van Ranst M
    Virology; 2013 Oct; 445(1-2):213-23. PubMed ID: 23711385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Virological and carcinogenic aspects of HPV].
    Prétet JL; Charlot JF; Mougin C
    Bull Acad Natl Med; 2007 Mar; 191(3):611-23; discussion 623. PubMed ID: 18072657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity.
    Hebner CM; Laimins LA
    Rev Med Virol; 2006; 16(2):83-97. PubMed ID: 16287204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High viral load of human wart-associated papillomaviruses (PV) but not beta-PV in cutaneous warts independent of immunosuppression.
    Köhler A; Meyer T; Stockfleth E; Nindl I
    Br J Dermatol; 2009 Sep; 161(3):528-35. PubMed ID: 19519829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillomavirus and treatment.
    Snoeck R
    Antiviral Res; 2006 Sep; 71(2-3):181-91. PubMed ID: 16831473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally occurring, nonregressing canine oral papillomavirus infection: host immunity, virus characterization, and experimental infection.
    Nicholls PK; Klaunberg BA; Moore RA; Santos EB; Parry NR; Gough GW; Stanley MA
    Virology; 1999 Dec; 265(2):365-74. PubMed ID: 10600607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.